Log in

PHIL Philogen SpA MIL · Italy

Philogen SpA (PHIL) news

Philogen SpA is a public biotech or pharmaceutical company listed on MIL under the ticker PHIL, recorded under Italy. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Philogen SpA news

We have not published a story on Philogen SpA yet. When there is news, it will appear here.

Questions about Philogen SpA

What is the ticker symbol of Philogen SpA?

Philogen SpA trades under the ticker PHIL on MIL.

Where is Philogen SpA listed?

Philogen SpA is listed on MIL. Our directory also records these other listings: LSX:A2QQB6.

Which country or territory is Philogen SpA listed under?

Our directory records Philogen SpA under Italy.

What does Philogen SpA do?

Our directory classifies Philogen SpA as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.

What is the ISIN of Philogen SpA?

The ISIN recorded for Philogen SpA is IT0005373789.

Does aibio.space cover Philogen SpA?

aibio.space lists Philogen SpA among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Philogen SpA?

Companies in our directory listed in the same country and business area as Philogen SpA: Fine Foods & Pharmaceuticals N.T.M. SpA, Newron Pharmaceuticals S.p.A., Recordati S.p.A., Arterra Bioscience SpA.

Investor discussion: Philogen SpA

Members talk about Philogen SpA (PHIL). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open MIL:PHIL on TradingView.

Listing details

Philogen SpA is a public biotech or pharmaceutical company listed on MIL under the ticker PHIL, recorded under Italy. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Philogen SpA
Ticker
PHIL
Listing
MIL
Country or territory
Italy
Business scope
Pharmaceuticals: Major
ISIN
IT0005373789
Other listed symbols
LSX:A2QQB6
Last quote in directory
2026-10-21
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.